1. Home
  2. AAPG vs CVCO Comparison

AAPG vs CVCO Comparison

Compare AAPG & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • CVCO
  • Stock Information
  • Founded
  • AAPG 2009
  • CVCO 1965
  • Country
  • AAPG China
  • CVCO United States
  • Employees
  • AAPG N/A
  • CVCO N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • CVCO Homebuilding
  • Sector
  • AAPG Health Care
  • CVCO Consumer Discretionary
  • Exchange
  • AAPG Nasdaq
  • CVCO Nasdaq
  • Market Cap
  • AAPG 3.6B
  • CVCO 3.6B
  • IPO Year
  • AAPG 2025
  • CVCO N/A
  • Fundamental
  • Price
  • AAPG $47.90
  • CVCO $519.55
  • Analyst Decision
  • AAPG Buy
  • CVCO Buy
  • Analyst Count
  • AAPG 1
  • CVCO 2
  • Target Price
  • AAPG N/A
  • CVCO $522.50
  • AVG Volume (30 Days)
  • AAPG 8.1K
  • CVCO 125.4K
  • Earning Date
  • AAPG 08-20-2025
  • CVCO 07-31-2025
  • Dividend Yield
  • AAPG N/A
  • CVCO N/A
  • EPS Growth
  • AAPG N/A
  • CVCO 34.06
  • EPS
  • AAPG N/A
  • CVCO 23.02
  • Revenue
  • AAPG $54,524,554.00
  • CVCO $2,094,716,000.00
  • Revenue This Year
  • AAPG N/A
  • CVCO $8.56
  • Revenue Next Year
  • AAPG $404.41
  • CVCO $6.08
  • P/E Ratio
  • AAPG N/A
  • CVCO $22.57
  • Revenue Growth
  • AAPG N/A
  • CVCO 16.60
  • 52 Week Low
  • AAPG $16.50
  • CVCO $388.69
  • 52 Week High
  • AAPG $48.45
  • CVCO $549.99
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • CVCO 74.72
  • Support Level
  • AAPG N/A
  • CVCO $477.41
  • Resistance Level
  • AAPG N/A
  • CVCO $497.25
  • Average True Range (ATR)
  • AAPG 0.00
  • CVCO 14.68
  • MACD
  • AAPG 0.00
  • CVCO 5.32
  • Stochastic Oscillator
  • AAPG 0.00
  • CVCO 94.67

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

Share on Social Networks: